Fig. 6From: Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ proteinRecruitment of T CD8+ lymphocytes, TNF-α and CD107a production in mice immunized with the recombinant DNA-MVA. A Representative graphs of the gating strategy used in the flow cytometry assays. The A3 peptide and PMA/Ionomycin were used as positive controls. B Graph of the total percentage of T CD8+ lymphocytes producers of TNF-α, expressing CD107a, recruited after restimulation with HBZ peptides. Statistical differences were observed between the group’s DNA-MVA vs Adjuvant. Legend (symbols): Circle: Cells from mice immunized with the recombinant DNA-MVA regimen; Square: Cells from mice inoculated only with the MVA (wt) vector; Triangle: Cells from mice inoculated only with the Addavax adjuvant. N = 7Back to article page